Park Ha Biological Technology Co. (BYAH) Income Statement

Park Ha Biological Technology Co. reported revenue of $2.52M in fiscal 2026 (fiscal year ended Oct 31, 2025). Park Ha Biological Technology Co. posted a net loss of $24.36M. Gross margin was 94.4% and operating margin -956.5%. In the most recent quarter, Q2 fiscal 2026 (ended Apr 30, 2026), revenue was $1.26M, up 1.5% from the same quarter a year earlier.

Park Ha Biological Technology Co. Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Park Ha Biological Technology Co., Ltd. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2024	FY 2023	FY 2022	FY 2021	FY 2017
Period ending	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021	Dec 2017
Revenue & Gross Profit
Revenue	2.52	2.38	2.46	1.92	0.93	456.00
Cost of Revenue	0.14	0.20	0.31	0.51	0.31	0.00
Gross Profit	2.38	2.19	2.15	1.41	0.62	456.00
Operating Expenses
Research & Development	0.24	0.04	0.03	0.06	0.05	0.00
Selling, General & Administrative	26.11	1.18	0.78	1.15	1.12	338.00
Operating Expenses	26.53	1.39	0.97	1.21	1.12	-752.00
Operating Income	-24.15	0.79	1.18	0.20	-0.50	-296.00
Other Income/Expense
Interest Income	0.01	0.00	0.00	0.00	0.00	-36.00
Interest Expense	0.00	0.00	0.00	0.00	0.00	73.00
Other Income/Expense	0.06	0.00	0.00	-0.01	0.02	23.00
Income
Income Before Tax	-24.08	0.79	1.18	0.19	-0.48	-273.00
Income Tax Expense	0.28	0.31	0.33	0.00	0.00	-79.00
Net Income	-24.36	0.48	0.85	0.19	-0.48	-194.00
Net Income - Continuous Operations	-24.36	0.48	0.85	0.19	-0.48	-194.00
Net Income - Discontinued Operations	-	-	-	-	-	-
EBITDA	-23.97	0.82	1.20	0.23	-0.44	-282.00
EBIT	-24.15	0.79	1.18	0.20	-0.48	-
Depreciation & Amortization	0.11	0.02	0.02	0.03	0.04	14.00
Earnings Per Share
Basic EPS	-331.00	8.00	13.00	3.00	-7.00	-4.00
Diluted EPS	-331.00	1.00	13.00	1.00	-7.00	-4.00
Basic Shares Outstanding	0.07	0.06	0.07	0.06	0.07	46.91
Diluted Shares Outstanding	0.07	0.06	0.07	0.06	0.07	46.91

Source: Company financial statements from annual and quarterly filings. Data as of Apr 30, 2026. Data sources and methodology

Frequently Asked Questions About Park Ha Biological Technology Co. Financial Statements

What was Park Ha Biological Technology Co.'s revenue in fiscal 2026?

Park Ha Biological Technology Co. reported revenue of $2.52M in fiscal 2026 (fiscal year ended Oct 31, 2025).

Is Park Ha Biological Technology Co. profitable?

No. Park Ha Biological Technology Co. reported a net loss of $24.36M in fiscal 2026.

What is Park Ha Biological Technology Co.'s operating margin?

Park Ha Biological Technology Co.'s operating income was −$24.15M on revenue of $2.52M in fiscal 2026, an operating margin of -956.5%.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition